Article Versions Notes

Gulde S, Foscarini A, April-Monn SL, Genio E, Marangelo A, Satam S, Helbling D, Falconi M, Toledo RA, Schrader J, et al. Combined Targeting of Pathogenetic Mechanisms in Pancreatic Neuroendocrine Tumors Elicits Synergistic Antitumor Effects. Cancers. 2022; 14(22):5481. https://doi.org/10.3390/cancers14225481

Gulde, Sebastian, Alessia Foscarini, Simon L. April-Monn, Edoardo Genio, Alessandro Marangelo, Swapna Satam, Daniel Helbling, Massimo Falconi, Rodrigo A. Toledo, Jörg Schrader, and et al. 2022. "Combined Targeting of Pathogenetic Mechanisms in Pancreatic Neuroendocrine Tumors Elicits Synergistic Antitumor Effects" Cancers 14, no. 22: 5481. https://doi.org/10.3390/cancers14225481

Gulde, S., Foscarini, A., April-Monn, S. L., Genio, E., Marangelo, A., Satam, S., Helbling, D., Falconi, M., Toledo, R. A., Schrader, J., Perren, A., Marinoni, I., & Pellegata, N. S. (2022). Combined Targeting of Pathogenetic Mechanisms in Pancreatic Neuroendocrine Tumors Elicits Synergistic Antitumor Effects. Cancers, 14(22), 5481. https://doi.org/10.3390/cancers14225481